Snowball logo
logo
EBS_logo

Emergent BioSolutions Inc

EBS β€’ NYSE
$4.49-$0.06Β  (1.32%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
1,773.61,117.51,049.31,043.6742.9770.2
COGS
980.4644.5689.3668.2392.3389.7
Gross Profit
793.2473360375.4350.6380.5
Operating Expenses & Income
Operating Income
341.4(170)(726.4)(108.7)110.2(54.4)
Total Operating Expenses
451.86431,086.4484.1240.4434.9
R&D Expenses
235.2188.3111.470.753.845.3
Selling General & Admin Expenses
347.5340.3372.9308186.1136.6
Earnings from Continuing Operations
Interest Expense
(34.5)(37.3)(87.9)(71)(59.3)(50.9)
Interest Income
34.537.387.97159.329.9
Income Tax Expense
83.7(7.4)29.347.730.230.8
Net Income
Net Income
219.5(211.6)(760.5)(190.6)52.6(176.8)
Supplemental
EBIT
386(109.3)(168.1)(52.2)142.1-
EBITDA
504.215.7(47)53.4240.4(23.7)
In millions of USD, except % and values per 1 share